APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vaginal Fungi Infections Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Vaginal Fungi Infections Treatment Industry Growth and Trends Forecast to 2032

19 December 2025103 pages

Choose your research edition.

Industry ResearchVaginal Fungi Infections Treatment Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaginal Fungi Infections Treatment Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Vaginal Fungi Infections Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaginal Fungi Infections Treatment Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaginal Fungi Infections Treatment Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

According to APO Research, the global Vaginal Fungi Infections Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Vaginal Fungi Infections Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Vaginal Fungi Infections Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vaginal Fungi Infections Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Vaginal Fungi Infections Treatment market include ANI Pharmaceuticals, Aurobindo Pharma Limited, Bausch Health Companies Inc, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals Limited, Hikma Pharmaceuticals Plc, Lupin Limited, Mycovia Pharmaceuticals and PEPTONIC medical AB, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Vaginal Fungi Infections Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Vaginal Fungi Infections Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vaginal Fungi Infections Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vaginal Fungi Infections Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Vaginal Fungi Infections Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Vaginal Fungi Infections Treatment Market by Company

ANI Pharmaceuticals

Aurobindo Pharma Limited

Bausch Health Companies Inc

Dr. Reddy's Laboratories

Glenmark Pharmaceuticals Limited

Hikma Pharmaceuticals Plc

Lupin Limited

Mycovia Pharmaceuticals

PEPTONIC medical AB

SCYNEXIS

Unique Pharmaceuticals

Pfizer Inc.

Vaginal Fungi Infections Treatment Segment by Type

Flucytosine

Fluconazole

Nystatin

Others

Vaginal Fungi Infections Treatment Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Vaginal Fungi Infections Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaginal Fungi Infections Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaginal Fungi Infections Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaginal Fungi Infections Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Vaginal Fungi Infections Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Vaginal Fungi Infections Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Vaginal Fungi Infections Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Vaginal Fungi Infections Treatment Market Share by Region (2021-2026) Table 4. Global Vaginal Fungi Infections Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Vaginal Fungi Infections Treatment Market Share by Region (2027-2032) Table 6. Global Vaginal Fungi Infections Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Vaginal Fungi Infections Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Vaginal Fungi Infections Treatment Market Size Share by Type (2021-2026) Table 9. Global Vaginal Fungi Infections Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Vaginal Fungi Infections Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Vaginal Fungi Infections Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Vaginal Fungi Infections Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Vaginal Fungi Infections Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Vaginal Fungi Infections Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Vaginal Fungi Infections Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Vaginal Fungi Infections Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Vaginal Fungi Infections Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Vaginal Fungi Infections Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Vaginal Fungi Infections Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Vaginal Fungi Infections Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Vaginal Fungi Infections Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Vaginal Fungi Infections Treatment Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Vaginal Fungi Infections Treatment Market Size Share by Application (2021-2026) Table 24. Global Vaginal Fungi Infections Treatment Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Vaginal Fungi Infections Treatment Market Size Share Forecasted by Application (2027-2032) Table 26. North America Vaginal Fungi Infections Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Vaginal Fungi Infections Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Vaginal Fungi Infections Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Vaginal Fungi Infections Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Vaginal Fungi Infections Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Vaginal Fungi Infections Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Vaginal Fungi Infections Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Vaginal Fungi Infections Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Vaginal Fungi Infections Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Vaginal Fungi Infections Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Vaginal Fungi Infections Treatment Industry Trends Table 37. Vaginal Fungi Infections Treatment Industry Drivers Table 38. Vaginal Fungi Infections Treatment Industry Opportunities and Challenges Table 39. Vaginal Fungi Infections Treatment Industry Restraints Table 40. Global Vaginal Fungi Infections Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Vaginal Fungi Infections Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Vaginal Fungi Infections Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Vaginal Fungi Infections Treatment Key Company Headquarters & Area Served Table 44. Global Vaginal Fungi Infections Treatment Company, Product Type & Application Table 45. Global Vaginal Fungi Infections Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Vaginal Fungi Infections Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. ANI Pharmaceuticals Company Information Table 49. ANI Pharmaceuticals Business Overview Table 50. ANI Pharmaceuticals Vaginal Fungi Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. ANI Pharmaceuticals Vaginal Fungi Infections Treatment Product Portfolio Table 52. ANI Pharmaceuticals Recent Development Table 53. Aurobindo Pharma Limited Company Information Table 54. Aurobindo Pharma Limited Business Overview Table 55. Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Product Portfolio Table 57. Aurobindo Pharma Limited Recent Development Table 58. Bausch Health Companies Inc Company Information Table 59. Bausch Health Companies Inc Business Overview Table 60. Bausch Health Companies Inc Vaginal Fungi Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Bausch Health Companies Inc Vaginal Fungi Infections Treatment Product Portfolio Table 62. Bausch Health Companies Inc Recent Development Table 63. Dr. Reddy's Laboratories Company Information Table 64. Dr. Reddy's Laboratories Business Overview Table 65. Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Product Portfolio Table 67. Dr. Reddy's Laboratories Recent Development Table 68. Glenmark Pharmaceuticals Limited Company Information Table 69. Glenmark Pharmaceuticals Limited Business Overview Table 70. Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Product Portfolio Table 72. Glenmark Pharmaceuticals Limited Recent Development Table 73. Hikma Pharmaceuticals Plc Company Information Table 74. Hikma Pharmaceuticals Plc Business Overview Table 75. Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Product Portfolio Table 77. Hikma Pharmaceuticals Plc Recent Development Table 78. Lupin Limited Company Information Table 79. Lupin Limited Business Overview Table 80. Lupin Limited Vaginal Fungi Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Lupin Limited Vaginal Fungi Infections Treatment Product Portfolio Table 82. Lupin Limited Recent Development Table 83. Mycovia Pharmaceuticals Company Information Table 84. Mycovia Pharmaceuticals Business Overview Table 85. Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Product Portfolio Table 87. Mycovia Pharmaceuticals Recent Development Table 88. PEPTONIC medical AB Company Information Table 89. PEPTONIC medical AB Business Overview Table 90. PEPTONIC medical AB Vaginal Fungi Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. PEPTONIC medical AB Vaginal Fungi Infections Treatment Product Portfolio Table 92. PEPTONIC medical AB Recent Development Table 93. SCYNEXIS Company Information Table 94. SCYNEXIS Business Overview Table 95. SCYNEXIS Vaginal Fungi Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. SCYNEXIS Vaginal Fungi Infections Treatment Product Portfolio Table 97. SCYNEXIS Recent Development Table 98. Unique Pharmaceuticals Company Information Table 99. Unique Pharmaceuticals Business Overview Table 100. Unique Pharmaceuticals Vaginal Fungi Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Unique Pharmaceuticals Vaginal Fungi Infections Treatment Product Portfolio Table 102. Unique Pharmaceuticals Recent Development Table 103. Pfizer Inc. Company Information Table 104. Pfizer Inc. Business Overview Table 105. Pfizer Inc. Vaginal Fungi Infections Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Pfizer Inc. Vaginal Fungi Infections Treatment Product Portfolio Table 107. Pfizer Inc. Recent Development Table 108. North America Vaginal Fungi Infections Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America Vaginal Fungi Infections Treatment Market Size by Country (2021-2026) & (US$ Million) Table 110. North America Vaginal Fungi Infections Treatment Market Share by Country (2021-2026) Table 111. North America Vaginal Fungi Infections Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America Vaginal Fungi Infections Treatment Market Share Forecast by Country (2027-2032) Table 113. Europe Vaginal Fungi Infections Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Vaginal Fungi Infections Treatment Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Vaginal Fungi Infections Treatment Market Share by Country (2021-2026) Table 116. Europe Vaginal Fungi Infections Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Vaginal Fungi Infections Treatment Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Vaginal Fungi Infections Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Vaginal Fungi Infections Treatment Market Size by Country (2021-2026) & (US$ Million) Table 120. Asia-Pacific Vaginal Fungi Infections Treatment Market Share by Country (2021-2026) Table 121. Asia-Pacific Vaginal Fungi Infections Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Asia-Pacific Vaginal Fungi Infections Treatment Market Share Forecast by Country (2027-2032) Table 123. Latin America Vaginal Fungi Infections Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Latin America Vaginal Fungi Infections Treatment Market Size by Country (2021-2026) & (US$ Million) Table 125. Latin America Vaginal Fungi Infections Treatment Market Share by Country (2021-2026) Table 126. Latin America Vaginal Fungi Infections Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Latin America Vaginal Fungi Infections Treatment Market Share Forecast by Country (2027-2032) Table 128. Middle East & Africa Vaginal Fungi Infections Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country (2021-2026) & (US$ Million) Table 130. Middle East & Africa Vaginal Fungi Infections Treatment Market Share by Country (2021-2026) Table 131. Middle East & Africa Vaginal Fungi Infections Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Middle East & Africa Vaginal Fungi Infections Treatment Market Share Forecast by Country (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Vaginal Fungi Infections Treatment Product Image Figure 3. Global Vaginal Fungi Infections Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Vaginal Fungi Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Vaginal Fungi Infections Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Vaginal Fungi Infections Treatment Market Share by Region (2021-2032) Figure 7. North America Vaginal Fungi Infections Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Vaginal Fungi Infections Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Vaginal Fungi Infections Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Vaginal Fungi Infections Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Vaginal Fungi Infections Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Flucytosine Image Figure 13. Global Flucytosine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Fluconazole Image Figure 15. Global Fluconazole Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Nystatin Image Figure 17. Global Nystatin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Vaginal Fungi Infections Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Vaginal Fungi Infections Treatment Market Share by Type 2025 VS 2032 Figure 22. North America Vaginal Fungi Infections Treatment Market Size Share by Type (2021-2032) Figure 23. Europe Vaginal Fungi Infections Treatment Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Vaginal Fungi Infections Treatment Market Size Share by Type (2021-2032) Figure 25. Latin America Vaginal Fungi Infections Treatment Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Vaginal Fungi Infections Treatment Market Size Share by Type (2021-2032) Figure 27. Hospital Pharmacies Image Figure 28. Global Hospital Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Online Pharmacies Image Figure 30. Global Online Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Retail Pharmacies Image Figure 32. Global Retail Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Vaginal Fungi Infections Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Vaginal Fungi Infections Treatment Market Share by Application 2025 VS 2032 Figure 35. North America Vaginal Fungi Infections Treatment Market Size Share by Application (2021-2032) Figure 36. Europe Vaginal Fungi Infections Treatment Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Vaginal Fungi Infections Treatment Market Size Share by Application (2021-2032) Figure 38. Latin America Vaginal Fungi Infections Treatment Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Vaginal Fungi Infections Treatment Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Vaginal Fungi Infections Treatment Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Vaginal Fungi Infections Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Vaginal Fungi Infections Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Vaginal Fungi Infections Treatment Market Share by Country (2021-2032) Figure 45. Europe Vaginal Fungi Infections Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Vaginal Fungi Infections Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Vaginal Fungi Infections Treatment Market Share by Country (2021-2032) Figure 48. Asia-Pacific Vaginal Fungi Infections Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Vaginal Fungi Infections Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Vaginal Fungi Infections Treatment Market Share by Country (2021-2032) Figure 51. Latin America Vaginal Fungi Infections Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Vaginal Fungi Infections Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Vaginal Fungi Infections Treatment Market Share by Country (2021-2032) Figure 54. Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Vaginal Fungi Infections Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Vaginal Fungi Infections Treatment Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Flucytosine
  • Fluconazole
  • Nystatin
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • ANI Pharmaceuticals
  • Aurobindo Pharma Limited
  • Bausch Health Companies Inc
  • Dr. Reddy's Laboratories
  • Glenmark Pharmaceuticals Limited
  • Hikma Pharmaceuticals Plc
  • Lupin Limited
  • Mycovia Pharmaceuticals
  • PEPTONIC medical AB
  • SCYNEXIS
  • Unique Pharmaceuticals
  • Pfizer Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Vaginal Fungi Infections Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Vaginal Fungi Infections Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Vaginal Fungi Infections Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Vaginal Fungi Infections Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Vaginal Fungi Infections Treatment Market Size (2021-2032)
  8. 1.5.1 North America Vaginal Fungi Infections Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Vaginal Fungi Infections Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Vaginal Fungi Infections Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Vaginal Fungi Infections Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Vaginal Fungi Infections Treatment Market Size Growth Rate (2021-2032)
2 Vaginal Fungi Infections Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Flucytosine
  3. 2.1.2 Fluconazole
  4. 2.1.3 Nystatin
  5. 2.1.4 Others
  6. 2.2 Global Vaginal Fungi Infections Treatment Market Size by Type
  7. 2.2.1 Global Vaginal Fungi Infections Treatment Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Vaginal Fungi Infections Treatment Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Vaginal Fungi Infections Treatment Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Vaginal Fungi Infections Treatment Market Size by Regions
  11. 2.3.1 North America Vaginal Fungi Infections Treatment Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Vaginal Fungi Infections Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Vaginal Fungi Infections Treatment Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Vaginal Fungi Infections Treatment Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Vaginal Fungi Infections Treatment Market Size Breakdown by Type (2021-2026)
3 Vaginal Fungi Infections Treatment Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital Pharmacies
  3. 3.1.2 Online Pharmacies
  4. 3.1.3 Retail Pharmacies
  5. 3.2 Global Vaginal Fungi Infections Treatment Market Size by Application
  6. 3.2.1 Global Vaginal Fungi Infections Treatment Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Vaginal Fungi Infections Treatment Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Vaginal Fungi Infections Treatment Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Vaginal Fungi Infections Treatment Market Size by Regions
  10. 3.3.1 North America Vaginal Fungi Infections Treatment Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Vaginal Fungi Infections Treatment Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Vaginal Fungi Infections Treatment Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Vaginal Fungi Infections Treatment Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Vaginal Fungi Infections Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Vaginal Fungi Infections Treatment Industry Trends
  2. 4.2 Vaginal Fungi Infections Treatment Industry Drivers
  3. 4.3 Vaginal Fungi Infections Treatment Industry Opportunities and Challenges
  4. 4.4 Vaginal Fungi Infections Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Vaginal Fungi Infections Treatment Revenue (2021-2026)
  2. 5.2 Global Vaginal Fungi Infections Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Vaginal Fungi Infections Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Vaginal Fungi Infections Treatment Company, Product Type & Application
  5. 5.5 Global Vaginal Fungi Infections Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Vaginal Fungi Infections Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Vaginal Fungi Infections Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Vaginal Fungi Infections Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 ANI Pharmaceuticals
  2. 6.1.1 ANI Pharmaceuticals Company Information
  3. 6.1.2 ANI Pharmaceuticals Business Overview
  4. 6.1.3 ANI Pharmaceuticals Vaginal Fungi Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 ANI Pharmaceuticals Vaginal Fungi Infections Treatment Product Portfolio
  6. 6.1.5 ANI Pharmaceuticals Recent Developments
  7. 6.2 Aurobindo Pharma Limited
  8. 6.2.1 Aurobindo Pharma Limited Company Information
  9. 6.2.2 Aurobindo Pharma Limited Business Overview
  10. 6.2.3 Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Product Portfolio
  12. 6.2.5 Aurobindo Pharma Limited Recent Developments
  13. 6.3 Bausch Health Companies Inc
  14. 6.3.1 Bausch Health Companies Inc Company Information
  15. 6.3.2 Bausch Health Companies Inc Business Overview
  16. 6.3.3 Bausch Health Companies Inc Vaginal Fungi Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Bausch Health Companies Inc Vaginal Fungi Infections Treatment Product Portfolio
  18. 6.3.5 Bausch Health Companies Inc Recent Developments
  19. 6.4 Dr. Reddy's Laboratories
  20. 6.4.1 Dr. Reddy's Laboratories Company Information
  21. 6.4.2 Dr. Reddy's Laboratories Business Overview
  22. 6.4.3 Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Product Portfolio
  24. 6.4.5 Dr. Reddy's Laboratories Recent Developments
  25. 6.5 Glenmark Pharmaceuticals Limited
  26. 6.5.1 Glenmark Pharmaceuticals Limited Company Information
  27. 6.5.2 Glenmark Pharmaceuticals Limited Business Overview
  28. 6.5.3 Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Product Portfolio
  30. 6.5.5 Glenmark Pharmaceuticals Limited Recent Developments
  31. 6.6 Hikma Pharmaceuticals Plc
  32. 6.6.1 Hikma Pharmaceuticals Plc Company Information
  33. 6.6.2 Hikma Pharmaceuticals Plc Business Overview
  34. 6.6.3 Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Product Portfolio
  36. 6.6.5 Hikma Pharmaceuticals Plc Recent Developments
  37. 6.7 Lupin Limited
  38. 6.7.1 Lupin Limited Company Information
  39. 6.7.2 Lupin Limited Business Overview
  40. 6.7.3 Lupin Limited Vaginal Fungi Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Lupin Limited Vaginal Fungi Infections Treatment Product Portfolio
  42. 6.7.5 Lupin Limited Recent Developments
  43. 6.8 Mycovia Pharmaceuticals
  44. 6.8.1 Mycovia Pharmaceuticals Company Information
  45. 6.8.2 Mycovia Pharmaceuticals Business Overview
  46. 6.8.3 Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Product Portfolio
  48. 6.8.5 Mycovia Pharmaceuticals Recent Developments
  49. 6.9 PEPTONIC medical AB
  50. 6.9.1 PEPTONIC medical AB Company Information
  51. 6.9.2 PEPTONIC medical AB Business Overview
  52. 6.9.3 PEPTONIC medical AB Vaginal Fungi Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 PEPTONIC medical AB Vaginal Fungi Infections Treatment Product Portfolio
  54. 6.9.5 PEPTONIC medical AB Recent Developments
  55. 6.10 SCYNEXIS
  56. 6.10.1 SCYNEXIS Company Information
  57. 6.10.2 SCYNEXIS Business Overview
  58. 6.10.3 SCYNEXIS Vaginal Fungi Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 SCYNEXIS Vaginal Fungi Infections Treatment Product Portfolio
  60. 6.10.5 SCYNEXIS Recent Developments
  61. 6.11 Unique Pharmaceuticals
  62. 6.11.1 Unique Pharmaceuticals Company Information
  63. 6.11.2 Unique Pharmaceuticals Business Overview
  64. 6.11.3 Unique Pharmaceuticals Vaginal Fungi Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Unique Pharmaceuticals Vaginal Fungi Infections Treatment Product Portfolio
  66. 6.11.5 Unique Pharmaceuticals Recent Developments
  67. 6.12 Pfizer Inc.
  68. 6.12.1 Pfizer Inc. Company Information
  69. 6.12.2 Pfizer Inc. Business Overview
  70. 6.12.3 Pfizer Inc. Vaginal Fungi Infections Treatment Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Pfizer Inc. Vaginal Fungi Infections Treatment Product Portfolio
  72. 6.12.5 Pfizer Inc. Recent Developments
7 North America
  1. 7.1 North America Vaginal Fungi Infections Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Vaginal Fungi Infections Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Vaginal Fungi Infections Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Vaginal Fungi Infections Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Vaginal Fungi Infections Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Vaginal Fungi Infections Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Vaginal Fungi Infections Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Vaginal Fungi Infections Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Vaginal Fungi Infections Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Vaginal Fungi Infections Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Vaginal Fungi Infections Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Vaginal Fungi Infections Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Vaginal Fungi Infections Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Vaginal Fungi Infections Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst